CABA today
$1.45+$0.00 (+0.00%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourStrong Bullish
15 minSymmetric Triangle
5 minStrong Bullish
Daily trend turns up above $1.63
Key levels
Resistance$1.83
Resistance$1.55
Support$1.39
Support$1.18
Latest news & SEC filings
AnalystCitigroup keeps Buy rating on Cabaletta Bio, cuts target to $8
AnalystCitigroup keeps Buy rating on Cabaletta Bio, cuts price target to $8
All CABA news →About Cabaletta Bio
Cabaletta Bio develops engineered T cell treatments for autoimmune conditions. Its main candidate, resecabtagene autoleucel, is a CD19-CAR T therapy intended to wipe out B cells and restore immune balance. The company runs studies in myositis, lupus, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris. It is based in the United States and uses outside manufacturers for its candidates.
Based on the company's 10-K filed Mar 23, 2026.
Nasdaq · Healthcare
Cabaletta Bio, Inc. (CABA)
What Is the Price Target for CABA?
SEPT Low Target
$3.00
SEPT Mid Target
$3.00
SEPT High Target
$3.00
Analyst Consensus
$3.00
Is CABA a Buy or Sell Right Now?
Thesis
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CABA.
Start Free Trial →Is CABA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$3.16
10
Moat Score
NONE
1/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with CABA?
Insider Signal
BUYING
8 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CABA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
10.26%
FCF Growth YoY
-46.3%
Revenue Trend
UNKNOWN
Dark Pool Trades for CABA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CABA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:04:31 | $1.46 | 4,550 | $$7K | SELL |
| 20:59:56 | $1.46 | 1,700 | $$2K | MIDPOINT |
| 20:59:46 | $1.46 | 2,988 | $$4K | MIDPOINT |
| 20:59:46 | $1.46 | 2,100 | $$3K | MIDPOINT |
| 20:59:20 | $1.46 | 1,200 | $$2K | SELL |
5 dark pool trades shown · $$18K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for CABA
PREVIEWSEPT Investing provides real-time options flow tracking for CABA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $1.5 | May 21 | 191 | $$5000 | 100 | BLOCK |
| PUT | $1.5 | May 21 | 191 | $$4000 | 100 | BLOCK |
| CALL | $5.5 | Jan 21 | 436 | $$35 | 1 | SWEEP |
| CALL | $2.5 | Jan 21 | 436 | $$45 | 1 | SWEEP |
4 options trades shown · 75% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Cabaletta Bio, Inc. (CABA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CABA — frequently asked questions
What is CABA stock price today?
Cabaletta Bio, Inc. (CABA) is at $1.45, up 0.00% (+$0.00) at the Nov 11, 2026 close.
Why is CABA stock moving today?
Latest CABA news — Nov 9, 2026: Citigroup keeps Buy rating on Cabaletta Bio, cuts target to $8 · Nov 9, 2026: Citigroup keeps Buy rating on Cabaletta Bio, cuts price target to $8
What is the CABA price target?
The average analyst price target for CABA is $3.00, ranging from $3 to $3, based on 1 analysts. Latest: Wells Fargo maintains on Aug 14, 2026.
What do analysts rate CABA?
Analyst ratings for CABA: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did CABA beat earnings?
CABA last reported on Aug 13, 2026: EPS -$0.34 vs -$0.37 expected — a beat of 8.8%.
Does CABA pay a dividend?
CABA does not currently pay a dividend.
What are CABA support and resistance levels?
Support: $1.39, $1.18, $0.99. Resistance: $1.55, $1.83, $2.14.
What are insiders doing with CABA?
Insider activity: BUYING, 8 buys and 0 sells in the last 90 days.
What is the latest news on CABA?
Nov 9, 2026: Citigroup keeps Buy rating on Cabaletta Bio, cuts target to $8 · Nov 9, 2026: Citigroup keeps Buy rating on Cabaletta Bio, cuts price target to $8